{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:15:42Z","timestamp":1787242542450,"version":"build-2736575974"},"reference-count":191,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,3,26]],"date-time":"2021-03-26T00:00:00Z","timestamp":1616716800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,3,26]],"date-time":"2021-03-26T00:00:00Z","timestamp":1616716800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Probiotics & Antimicro. Prot."],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1007\/s12602-021-09773-9","type":"journal-article","created":{"date-parts":[[2021,3,26]],"date-time":"2021-03-26T12:02:58Z","timestamp":1616760178000},"page":"1239-1253","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["The Role of Mucosal Immunity and Recombinant Probiotics in SARS-CoV2 Vaccine Development"],"prefix":"10.1007","volume":"13","author":[{"given":"Shima","family":"Moradi-kalbolandi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keyvan","family":"Majidzadeh-A","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohadeseh Haji","family":"Abdolvahab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neda","family":"Jalili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leila","family":"Farahmand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,26]]},"reference":[{"issue":"4","key":"9773_CR1","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.dsx.2020.04.015","volume":"14","author":"R Jayawardena","year":"2020","unstructured":"Jayawardena R, Sooriyaarachchi P, Chourdakis M, Jeewandara C, Ranasinghe P (2020) Enhancing immunity in viral infections, with special emphasis on COVID-19: a review. Diabetes Metab Syndr 14(4):367\u2013382. https:\/\/doi.org\/10.1016\/j.dsx.2020.04.015","journal-title":"Diabetes Metab Syndr"},{"issue":"7","key":"9773_CR2","doi-asserted-by":"publisher","first-page":"2967","DOI":"10.1007\/s00253-015-6498-0","volume":"99","author":"A Wyszynska","year":"2015","unstructured":"Wyszynska A, Kobierecka P, Bardowski J, Jagusztyn-Krynicka EK (2015) Lactic acid bacteria\u201320 years exploring their potential as live vectors for mucosal vaccination. Appl Microbiol Biotechnol 99(7):2967\u20132977. https:\/\/doi.org\/10.1007\/s00253-015-6498-0","journal-title":"Appl Microbiol Biotechnol"},{"issue":"6","key":"9773_CR3","doi-asserted-by":"publisher","first-page":"710","DOI":"10.2174\/1381612824666180116163411","volume":"24","author":"O Kanauchi","year":"2018","unstructured":"Kanauchi O, Andoh A, AbuBakar S, Yamamoto N (2018) Probiotics and paraprobiotics in viral infection: clinical application and effects on the innate and acquired immune systems. Curr Pharm Des 24(6):710\u2013717. https:\/\/doi.org\/10.2174\/1381612824666180116163411","journal-title":"Curr Pharm Des"},{"issue":"1","key":"9773_CR4","doi-asserted-by":"publisher","first-page":"2","DOI":"10.4082\/kjfm.2013.34.1.2","volume":"34","author":"EJ Kang","year":"2013","unstructured":"Kang EJ, Kim SY, Hwang IH, Ji YJ (2013) The effect of probiotics on prevention of common cold: a meta-analysis of randomized controlled trial studies. Korean J Fam Med 34(1):2\u201310. https:\/\/doi.org\/10.4082\/kjfm.2013.34.1.2","journal-title":"Korean J Fam Med"},{"key":"9773_CR5","doi-asserted-by":"publisher","unstructured":"Pedrolli DB, Ribeiro NV, Squizato PN, Cozetto DA, de Jesus VN, Freire PJC, Lins MRCR, Correa GG (2020) Chapter 8 - Engineering microbial living therapeutics. In: Faintuch J, Faintuch S (eds) Precision medicine for investigators, practitioners and providers. Academic Press, pp 71\u201382. https:\/\/doi.org\/10.1016\/B978-0-12-819178-1.00008-3","DOI":"10.1016\/B978-0-12-819178-1.00008-3"},{"key":"9773_CR6","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.cbpa.2017.04.011","volume":"40","author":"KJ Chua","year":"2017","unstructured":"Chua KJ, Kwok WC, Aggarwal N, Sun T, Chang MW (2017) Designer probiotics for the prevention and treatment of human diseases. Curr Opin Chem Biol 40:8\u201316. https:\/\/doi.org\/10.1016\/j.cbpa.2017.04.011","journal-title":"Current Opinion in Chemical Biology"},{"key":"9773_CR7","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.fsi.2018.02.025","volume":"75","author":"FA Guardiola","year":"2018","unstructured":"Guardiola FA, Bahi A, Jimenez-Monreal AM, Martinez-Tome M, Murcia MA, Esteban MA (2018) Dietary administration effects of fenugreek seeds on skin mucosal antioxidant and immunity status of gilthead seabream (Sparus aurata L.). Fish Shellfish Immunol 75:357\u2013364. https:\/\/doi.org\/10.1016\/j.fsi.2018.02.025","journal-title":"Fish Shellfish Immunol"},{"issue":"3","key":"9773_CR8","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s00394-010-0127-6","volume":"50","author":"A Berggren","year":"2011","unstructured":"Berggren A, Lazou Ahren I, Larsson N, Onning G (2011) Randomised, double-blind and placebo-controlled study using new probiotic lactobacilli for strengthening the body immune defence against viral infections. Eur J Nutr 50(3):203\u2013210. https:\/\/doi.org\/10.1007\/s00394-010-0127-6","journal-title":"Eur J Nutr"},{"issue":"44\u201346","key":"9773_CR9","doi-asserted-by":"publisher","first-page":"6670","DOI":"10.1016\/j.vaccine.2006.05.048","volume":"24","author":"M de Vrese","year":"2006","unstructured":"de Vrese M, Winkler P, Rautenberg P, Harder T, Noah C, Laue C, Ott S, Hampe J, Schreiber S, Heller K, Schrezenmeir J (2006) Probiotic bacteria reduced duration and severity but not the incidence of common cold episodes in a double blind, randomized, controlled trial. Vaccine 24(44\u201346):6670\u20136674. https:\/\/doi.org\/10.1016\/j.vaccine.2006.05.048","journal-title":"Vaccine"},{"issue":"41","key":"9773_CR10","doi-asserted-by":"publisher","first-page":"5677","DOI":"10.1016\/j.vaccine.2009.06.094","volume":"27","author":"T Boge","year":"2009","unstructured":"Boge T, Remigy M, Vaudaine S, Tanguy J, Bourdet-Sicard R, van der Werf S (2009) A probiotic fermented dairy drink improves antibody response to influenza vaccination in the elderly in two randomised controlled trials. Vaccine 27(41):5677\u20135684. https:\/\/doi.org\/10.1016\/j.vaccine.2009.06.094","journal-title":"Vaccine"},{"issue":"1877","key":"9773_CR11","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.3389\/fmicb.2020.01877","volume":"11","author":"SK Tiwari","year":"2020","unstructured":"Tiwari SK, Dicks LMT, Popov IV, Karaseva A, Ermakov AM, Suvorov A, Tagg JR, Weeks R, Chikindas ML (2020) Probiotics at war against viruses: what is missingfrom the picture? Front Microbiol 11(1877):1877. https:\/\/doi.org\/10.3389\/fmicb.2020.01877","journal-title":"Front Microbiol"},{"issue":"4","key":"9773_CR12","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1021\/sb500258b","volume":"4","author":"J Claesen","year":"2015","unstructured":"Claesen J, Fischbach MA (2015) Synthetic microbes as drug delivery systems. ACS Synth Biol 4(4):358\u2013364. https:\/\/doi.org\/10.1021\/sb500258b","journal-title":"ACS Synth Biol"},{"key":"9773_CR13","doi-asserted-by":"publisher","first-page":"198103","DOI":"10.1016\/j.virusres.2020.198103","volume":"286","author":"S Ahlawat","year":"2020","unstructured":"Ahlawat S, Asha Sharma KK (2020) Immunological co-ordination between gut and lungs in SARS-CoV-2 infection. Virus Res 286:198103. https:\/\/doi.org\/10.1016\/j.virusres.2020.198103","journal-title":"Virus Res"},{"issue":"5","key":"9773_CR14","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41577-020-0308-3","volume":"20","author":"X Cao","year":"2020","unstructured":"Cao X (2020) COVID-19: immunopathology and its implications for therapy. Nat Rev Immunol 20(5):269\u2013270. https:\/\/doi.org\/10.1038\/s41577-020-0308-3","journal-title":"Nat Rev Immunol"},{"key":"9773_CR15","doi-asserted-by":"publisher","unstructured":"Chen WH, Strych U, Hotez PJ, Bottazzi ME (2020) The SARS-CoV-2 vaccine pipeline: an overview. Curr Trop Med Rep:1\u20134. https:\/\/doi.org\/10.1007\/s40475-020-00201-6","DOI":"10.1007\/s40475-020-00201-6"},{"issue":"5","key":"9773_CR16","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.it.2020.03.007","volume":"41","author":"S Jiang","year":"2020","unstructured":"Jiang S, Hillyer C, Du L (2020) Neutralizing antibodies against SARS-CoV-2 and other human Coronaviruses. Trends Immunol 41(5):355\u2013359. https:\/\/doi.org\/10.1016\/j.it.2020.03.007","journal-title":"Trends Immunol"},{"issue":"7798","key":"9773_CR17","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","volume":"579","author":"P Zhou","year":"2020","unstructured":"Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, Si HR, Zhu Y, Li B, Huang CL, Chen HD, Chen J, Luo Y, Guo H, Jiang RD, Liu MQ, Chen Y, Shen XR, Wang X, Zheng XS, Zhao K, Chen QJ, Deng F, Liu LL, Yan B, Zhan FX, Wang YY, Xiao GF, Shi ZL (2020) A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579(7798):270\u2013273. https:\/\/doi.org\/10.1038\/s41586-020-2012-7","journal-title":"Nature"},{"issue":"6","key":"9773_CR18","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/s41423-020-0400-4","volume":"17","author":"W Tai","year":"2020","unstructured":"Tai W, He L, Zhang X, Pu J, Voronin D, Jiang S, Zhou Y, Du L (2020) Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine. Cell Mol Immunol 17(6):613\u2013620. https:\/\/doi.org\/10.1038\/s41423-020-0400-4","journal-title":"Cell Mol Immunol"},{"key":"9773_CR19","doi-asserted-by":"publisher","unstructured":"Xiao F, Tang M, Zheng X, Liu Y, Li X, Shan H (2020) Evidence for gastrointestinal infection of SARS-CoV-2. Gastroenterology 158 (6):1831\u20131833 e1833. https:\/\/doi.org\/10.1053\/j.gastro.2020.02.055","DOI":"10.1053\/j.gastro.2020.02.055"},{"issue":"10223","key":"9773_CR20","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan. China. Lancet 395(10223):497\u2013506. https:\/\/doi.org\/10.1016\/S0140-6736(20)30183-5","journal-title":"China. Lancet"},{"issue":"5","key":"9773_CR21","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.kint.2020.03.005","volume":"97","author":"Y Cheng","year":"2020","unstructured":"Cheng Y, Luo R, Wang K, Zhang M, Wang Z, Dong L, Li J, Yao Y, Ge S, Xu G (2020) Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int 97(5):829\u2013838. https:\/\/doi.org\/10.1016\/j.kint.2020.03.005","journal-title":"Kidney Int"},{"issue":"2","key":"9773_CR22","doi-asserted-by":"publisher","first-page":"100","DOI":"10.3760\/cma.j.issn.1007-3418.2020.02.002","volume":"28","author":"GW Guan","year":"2020","unstructured":"Guan GW, Gao L, Wang JW, Wen XJ, Mao TH, Peng SW, Zhang T, Chen XM, Lu FM (2020) Exploring the mechanism of liver enzyme abnormalities in patients with novel coronavirus-infected pneumonia. Zhonghua Gan Zang Bing Za Zhi 28(2):100\u2013106. https:\/\/doi.org\/10.3760\/cma.j.issn.1007-3418.2020.02.002","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"issue":"11","key":"9773_CR23","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1001\/jama.2020.1585","volume":"323","author":"D Wang","year":"2020","unstructured":"Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, Zhao Y, Li Y, Wang X, Peng Z (2020) Clinical characteristics of 138 hospitalized patients with 2019 novel Coronavirus-Infected pneumonia in Wuhan, China. JAMA 323(11):1061\u20131069. https:\/\/doi.org\/10.1001\/jama.2020.1585","journal-title":"China. JAMA"},{"issue":"2","key":"9773_CR24","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s11684-020-0754-0","volume":"14","author":"X Zou","year":"2020","unstructured":"Zou X, Chen K, Zou J, Han P, Hao J, Han Z (2020) Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection. Front Med 14(2):185\u2013192. https:\/\/doi.org\/10.1007\/s11684-020-0754-0","journal-title":"Front Med"},{"key":"9773_CR25","doi-asserted-by":"publisher","unstructured":"Meyer NJ, Christie JD (2013) Genetic heterogeneity and risk of acute respiratory distress syndrome. In: Semin Respir Crit Care Med, 2013. vol 04. Thieme Medical Publishers, pp 459\u2013474. https:\/\/doi.org\/10.1055\/s-0033-1351121","DOI":"10.1055\/s-0033-1351121"},{"issue":"6","key":"9773_CR26","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1056\/NEJMra1608077","volume":"377","author":"BT Thompson","year":"2017","unstructured":"Thompson BT, Chambers RC, Liu KD (2017) Acute respiratory distress syndrome. N Engl J Med 377(6):562\u2013572. https:\/\/doi.org\/10.1056\/NEJMra1608077","journal-title":"N Engl J Med"},{"issue":"6","key":"9773_CR27","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1002\/rmv.405","volume":"13","author":"A Takada","year":"2003","unstructured":"Takada A, Kawaoka Y (2003) Antibody-dependent enhancement of viral infection: molecular mechanisms and in vivo implications. Rev Med Virol 13(6):387\u2013398. https:\/\/doi.org\/10.1002\/rmv.405","journal-title":"Rev Med Virol"},{"issue":"3","key":"9773_CR28","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/nrmicro2090","volume":"7","author":"L Du","year":"2009","unstructured":"Du L, He Y, Zhou Y, Liu S, Zheng BJ, Jiang S (2009) The spike protein of SARS-CoV\u2013a target for vaccine and therapeutic development. Nat Rev Microbiol 7(3):226\u2013236. https:\/\/doi.org\/10.1038\/nrmicro2090","journal-title":"Nat Rev Microbiol"},{"issue":"3","key":"9773_CR29","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1007\/s12250-020-00207-4","volume":"35","author":"Y Fu","year":"2020","unstructured":"Fu Y, Cheng Y, Wu Y (2020) Understanding SARS-CoV-2-mediated inflammatory responses: from mechanisms to potential therapeutic tools. Virol Sin 35(3):266\u2013271. https:\/\/doi.org\/10.1007\/s12250-020-00207-4","journal-title":"Virol Sin"},{"issue":"1","key":"9773_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.12932\/AP-200220-0772","volume":"38","author":"E Prompetchara","year":"2020","unstructured":"Prompetchara E, Ketloy C, Palaga T (2020) Immune responses in COVID-19 and potential vaccines: lessons learned from SARS and MERS epidemic. Asian Pac J Allergy Immunol 38(1):1\u20139. https:\/\/doi.org\/10.12932\/AP-200220-0772","journal-title":"Asian Pac J Allergy Immunol"},{"issue":"2","key":"9773_CR31","doi-asserted-by":"publisher","first-page":"216","DOI":"10.14336\/ad.2020.0228","volume":"11","author":"Z Leng","year":"2020","unstructured":"Leng Z, Zhu R, Hou W, Feng Y, Yang Y, Han Q, Shan G, Meng F, Du D, Wang S, Fan J, Wang W, Deng L, Shi H, Li H, Hu Z, Zhang F, Gao J, Liu H, Li X, Zhao Y, Yin K, He X, Gao Z, Wang Y, Yang B, Jin R, Stambler I, Lim LW, Su H, Moskalev A, Cano A, Chakrabarti S, Min KJ, Ellison-Hughes G, Caruso C, Jin K, Zhao RC (2020) Transplantation of ACE2(-) mesenchymal stem cells improves the outcome of patients with COVID-19 Pneumonia. Aging Dis 11(2):216\u2013228. https:\/\/doi.org\/10.14336\/ad.2020.0228","journal-title":"Aging Dis"},{"issue":"5","key":"9773_CR32","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1038\/s41418-020-0530-3","volume":"27","author":"Y Shi","year":"2020","unstructured":"Shi Y, Wang Y, Shao C, Huang J, Gan J, Huang X, Bucci E, Piacentini M, Ippolito G, Melino G (2020) COVID-19 infection: the perspectives on immune responses. Cell Death Differ 27(5):1451\u20131454. https:\/\/doi.org\/10.1038\/s41418-020-0530-3","journal-title":"Cell Death Differ"},{"key":"9773_CR33","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.antiviral.2016.11.006","volume":"137","author":"WJ Liu","year":"2017","unstructured":"Liu WJ, Zhao M, Liu K, Xu K, Wong G, Tan W, Gao GF (2017) T-cell immunity of SARS-CoV: implications for vaccine development against MERS-CoV. Antiviral Res 137:82\u201392. https:\/\/doi.org\/10.1016\/j.antiviral.2016.11.006","journal-title":"Antiviral Res"},{"issue":"3","key":"9773_CR34","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1111\/imm.13223","volume":"160","author":"M Tan","year":"2020","unstructured":"Tan M, Liu Y, Zhou R, Deng X, Li F, Liang K, Shi Y (2020) Immunopathological characteristics of coronavirus disease 2019 cases in Guangzhou, China. Immunology 160(3):261\u2013268. https:\/\/doi.org\/10.1111\/imm.13223","journal-title":"China. Immunology"},{"key":"9773_CR35","doi-asserted-by":"publisher","first-page":"104236","DOI":"10.1016\/j.micpath.2020.104236","volume":"145","author":"P Kalita","year":"2020","unstructured":"Kalita P, Padhi AK, Zhang KYJ, Tripathi T (2020) Design of a peptide-based subunit vaccine against novel coronavirus SARS-CoV-2. Microb Pathog 145:104236. https:\/\/doi.org\/10.1016\/j.micpath.2020.104236","journal-title":"Microb Pathog"},{"issue":"5","key":"9773_CR36","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/d41573-020-00073-5","volume":"19","author":"T Le Thanh","year":"2020","unstructured":"Le Thanh T, Andreadakis Z, Kumar A, Gomez Roman R, Tollefsen S, Saville M, Mayhew S (2020) The COVID-19 vaccine development landscape. Nat Rev Drug Discov 19(5):305\u2013306. https:\/\/doi.org\/10.1038\/d41573-020-00073-5","journal-title":"Nat Rev Drug Discov"},{"issue":"6486","key":"9773_CR37","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1126\/science.368.6486.14","volume":"368","author":"J Cohen","year":"2020","unstructured":"Cohen J (2020) Vaccine designers take first shots at COVID-19. Science 368(6486):14\u201316. https:\/\/doi.org\/10.1126\/science.368.6486.14","journal-title":"Science"},{"issue":"2","key":"9773_CR38","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.jpha.2020.03.001","volume":"10","author":"X Li","year":"2020","unstructured":"Li X, Geng M, Peng Y, Meng L, Lu S (2020) Molecular immune pathogenesis and diagnosis of COVID-19. J Pharm Anal 10(2):102\u2013108. https:\/\/doi.org\/10.1016\/j.jpha.2020.03.001","journal-title":"J Pharm Anal"},{"key":"9773_CR39","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.jconrel.2018.09.006","volume":"288","author":"J Tomar","year":"2018","unstructured":"Tomar J, Patil HP, Bracho G, Tonnis WF, Frijlink HW, Petrovsky N, Vanbever R, Huckriede A, Hinrichs WLJ (2018) Advax augments B and T cell responses upon influenza vaccination via the respiratory tract and enables complete protection of mice against lethal influenza virus challenge. J Control Release 288:199\u2013211. https:\/\/doi.org\/10.1016\/j.jconrel.2018.09.006","journal-title":"J Control Release"},{"key":"9773_CR40","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.biomaterials.2018.10.041","volume":"192","author":"MA Islam","year":"2019","unstructured":"Islam MA, Firdous J, Badruddoza AZM, Reesor E, Azad M, Hasan A, Lim M, Cao W, Guillemette S, Cho CS (2019) M cell targeting engineered biomaterials for effective vaccination. Biomaterials 192:75\u201394. https:\/\/doi.org\/10.1016\/j.biomaterials.2018.10.041","journal-title":"Biomaterials"},{"issue":"10","key":"9773_CR41","doi-asserted-by":"publisher","first-page":"4272","DOI":"10.1128\/IAI.61.10.4272-4279.1993","volume":"61","author":"RJ Jackson","year":"1993","unstructured":"Jackson RJ, Fujihashi K, Xu-Amano J, Kiyono H, Elson CO, McGhee JR (1993) Optimizing oral vaccines: induction of systemic and mucosal B-cell and antibody responses to tetanus toxoid by use of cholera toxin as an adjuvant. Infect Immun 61(10):4272\u20134279. https:\/\/doi.org\/10.1128\/IAI.61.10.4272-4279.1993","journal-title":"Infect Immun"},{"issue":"6","key":"9773_CR42","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1517\/17425247.3.6.747","volume":"3","author":"EC Lavelle","year":"2006","unstructured":"Lavelle EC, O\u2019Hagan DT (2006) Delivery systems and adjuvants for oral vaccines. Expert Opin Drug Deliv 3(6):747\u2013762. https:\/\/doi.org\/10.1517\/17425247.3.6.747","journal-title":"Expert Opin Drug Deliv"},{"issue":"4 Suppl","key":"9773_CR43","doi-asserted-by":"publisher","first-page":"S45","DOI":"10.1038\/nm1213","volume":"11","author":"J Holmgren","year":"2005","unstructured":"Holmgren J, Czerkinsky C (2005) Mucosal immunity and vaccines. Nat Med 11(4 Suppl):S45-53. https:\/\/doi.org\/10.1038\/nm1213","journal-title":"Nat Med"},{"key":"9773_CR44","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.3389\/fimmu.2019.02299","volume":"10","author":"S Wang","year":"2019","unstructured":"Wang S, Geng N, Zhou D, Qu Y, Shi M, Xu Y, Liu K, Liu Y, Liu J (2019) Oral immunization of chickens with recombinant Lactobacillus plantarum vaccine against early ALV-J infection. Front Immunol 10:2299. https:\/\/doi.org\/10.3389\/fimmu.2019.02299","journal-title":"Front Immunol"},{"key":"9773_CR45","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.imlet.2019.10.013","volume":"217","author":"M Li","year":"2020","unstructured":"Li M, Wang Y, Sun Y, Cui H, Zhu SJ, Qiu HJ (2020) Mucosal vaccines: strategies and challenges. Immunol Lett 217:116\u2013125. https:\/\/doi.org\/10.1016\/j.imlet.2019.10.013","journal-title":"Immunol Lett"},{"issue":"4","key":"9773_CR46","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.immuni.2010.09.013","volume":"33","author":"K Chen","year":"2010","unstructured":"Chen K, Cerutti A (2010) Vaccination strategies to promote mucosal antibody responses. Immunity 33(4):479\u2013491. https:\/\/doi.org\/10.1016\/j.immuni.2010.09.013","journal-title":"Immunity"},{"issue":"1","key":"9773_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s13770-017-0082-x","volume":"15","author":"HB Lee","year":"2018","unstructured":"Lee HB, Yoon SY, Singh B, Oh SH, Cui L, Yan C, Kang SK, Choi YJ, Cho CS (2018) Oral immunization of FMDV vaccine using pH-sensitive and mucoadhesive thiolated cellulose acetate phthalate microparticles. Tissue Eng Regen Med 15(1):1\u201311. https:\/\/doi.org\/10.1007\/s13770-017-0082-x","journal-title":"Tissue Eng Regen Med"},{"issue":"8","key":"9773_CR48","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1038\/nri3251","volume":"12","author":"N Lycke","year":"2012","unstructured":"Lycke N (2012) Recent progress in mucosal vaccine development: potential and limitations. Nat Rev Immunol 12(8):592\u2013605. https:\/\/doi.org\/10.1038\/nri3251","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"9773_CR49","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.ejpb.2012.01.010","volume":"81","author":"WJ Lee","year":"2012","unstructured":"Lee WJ, Cha S, Shin M, Jung M, Islam MA, Cho CS, Yoo HS (2012) Efficacy of thiolated eudragit microspheres as an oral vaccine delivery system to induce mucosal immunity against enterotoxigenic Escherichia coli in mice. Eur J Pharm Biopharm 81(1):43\u201348. https:\/\/doi.org\/10.1016\/j.ejpb.2012.01.010","journal-title":"Eur J Pharm Biopharm"},{"key":"9773_CR50","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.jconrel.2016.02.014","volume":"240","author":"AK Shakya","year":"2016","unstructured":"Shakya AK, Chowdhury MYE, Tao W, Gill HS (2016) Mucosal vaccine delivery: current state and a pediatric perspective. J Control Release 240:394\u2013413. https:\/\/doi.org\/10.1016\/j.jconrel.2016.02.014","journal-title":"J Control Release"},{"issue":"1","key":"9773_CR51","doi-asserted-by":"publisher","first-page":"102","DOI":"10.2174\/1573395514666180605092054","volume":"15","author":"PA Kozlowski","year":"2019","unstructured":"Kozlowski PA, Aldovini A (2019) Mucosal vaccine approaches for prevention of HIV and SIV transmission. Curr Immunol Rev 15(1):102\u2013122. https:\/\/doi.org\/10.2174\/1573395514666180605092054","journal-title":"Curr Immunol Rev"},{"issue":"8","key":"9773_CR52","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.4155\/tde.11.68","volume":"2","author":"C Foged","year":"2011","unstructured":"Foged C (2011) Subunit vaccines of the future: the need for safe, customized and optimized particulate delivery systems. Ther Deliv 2(8):1057\u20131077. https:\/\/doi.org\/10.4155\/tde.11.68","journal-title":"Ther Deliv"},{"key":"9773_CR53","doi-asserted-by":"publisher","unstructured":"Pedersen G, Cox R (2012) The mucosal vaccine quandary: intranasal vs. sublingual immunization against influenza. Hum Vaccin Immunother 8 (5):689\u2013693. https:\/\/doi.org\/10.4161\/hv.19568","DOI":"10.4161\/hv.19568"},{"key":"9773_CR54","doi-asserted-by":"publisher","unstructured":"Czerkinsky C, Holmgren J (2012) Mucosal delivery routes for optimal immunization: targeting immunity to the right tissues. In: Kozlowski PA (ed) Mucosal vaccines: modern concepts, strategies, and challenges. Springer Berlin Heidelberg, Berlin, Heidelberg, pp 1\u201318. https:\/\/doi.org\/10.1007\/82_2010","DOI":"10.1007\/82_2010"},{"issue":"2","key":"9773_CR55","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/nri1777","volume":"6","author":"MR Neutra","year":"2006","unstructured":"Neutra MR, Kozlowski PA (2006) Mucosal vaccines: the promise and the challenge. Nat Rev Immunol 6(2):148\u2013158. https:\/\/doi.org\/10.1038\/nri1777","journal-title":"Nat Rev Immunol"},{"key":"9773_CR56","doi-asserted-by":"publisher","unstructured":"Emmer KL, Ertl HCJ (2020) Chapter 24 - Recombinant adenovirus vectors as mucosal vaccines. In: Kiyono H, Pascual DW (eds) Mucosal vaccines (Second Edition). Academic Press, pp 419\u2013444. https:\/\/doi.org\/10.1016\/B978-0-12-811924-2.00024-9","DOI":"10.1016\/B978-0-12-811924-2.00024-9"},{"key":"9773_CR57","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.addr.2017.04.008","volume":"114","author":"JE Vela Ramirez","year":"2017","unstructured":"Vela Ramirez JE, Sharpe LA, Peppas NA (2017) Current state and challenges in developing oral vaccines. Adv Drug Deliv Rev 114:116\u2013131. https:\/\/doi.org\/10.1016\/j.addr.2017.04.008","journal-title":"Adv Drug Deliv Rev"},{"issue":"6","key":"9773_CR58","first-page":"695","volume":"23","author":"AM Payne","year":"1960","unstructured":"Payne AM (1960) Oral immunization against poliomyelitis. Bull World Health Organ 23(6):695\u2013703","journal-title":"Bull World Health Organ"},{"key":"9773_CR59","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.ejpb.2017.11.001","volume":"122","author":"TF Bahamondez-Canas","year":"2018","unstructured":"Bahamondez-Canas TF, Cui Z (2018) Intranasal immunization with dry powder vaccines. Eur J Pharm Biopharm 122:167\u2013175. https:\/\/doi.org\/10.1016\/j.ejpb.2017.11.001","journal-title":"Eur J Pharm Biopharm"},{"issue":"3","key":"9773_CR60","doi-asserted-by":"publisher","first-page":"e85","DOI":"10.1038\/emm.2013.165","volume":"46","author":"SH Kim","year":"2014","unstructured":"Kim SH, Jang YS (2014) Antigen targeting to M cells for enhancing the efficacy of mucosal vaccines. Exp Mol Med 46(3):e85. https:\/\/doi.org\/10.1038\/emm.2013.165","journal-title":"Exp Mol Med"},{"issue":"6","key":"9773_CR61","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/mi.2010.55","volume":"3","author":"C Czerkinsky","year":"2010","unstructured":"Czerkinsky C, Holmgren J (2010) Topical immunization strategies. Mucosal Immunol 3(6):545\u2013555. https:\/\/doi.org\/10.1038\/mi.2010.55","journal-title":"Mucosal Immunol"},{"key":"9773_CR62","doi-asserted-by":"publisher","unstructured":"Quiding M, Nordstrom I, Kilander A, Andersson G, Hanson LA, Holmgren J, Czerkinsky C (1991) Intestinal immune responses in humans. Oral cholera vaccination induces strong intestinal antibody responses and interferon-gamma production and evokes local immunological memory. J Clin Invest 88 (1):143\u2013148. https:\/\/doi.org\/10.1172\/JCI115270","DOI":"10.1172\/JCI115270"},{"issue":"3","key":"9773_CR63","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1006\/smim.1999.0175","volume":"11","author":"PJ Sansonetti","year":"1999","unstructured":"Sansonetti PJ, Phalipon A (1999) M cells as ports of entry for enteroinvasive pathogens: mechanisms of interaction, consequences for the disease process. Semin Immunol 11(3):193\u2013203. https:\/\/doi.org\/10.1006\/smim.1999.0175","journal-title":"Semin Immunol"},{"issue":"15","key":"9773_CR64","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1016\/j.vaccine.2004.11.010","volume":"23","author":"LC Freytag","year":"2005","unstructured":"Freytag LC, Clements JD (2005) Mucosal adjuvants. Vaccine 23(15):1804\u20131813. https:\/\/doi.org\/10.1016\/j.vaccine.2004.11.010","journal-title":"Vaccine"},{"issue":"8","key":"9773_CR65","doi-asserted-by":"publisher","first-page":"423","DOI":"10.2183\/pjab.91.423","volume":"91","author":"H Kiyono","year":"2015","unstructured":"Kiyono H, Azegami T (2015) The mucosal immune system: from dentistry to vaccine development. Proc Jpn Acad Ser B Phys Biol Sci 91(8):423\u2013439. https:\/\/doi.org\/10.2183\/pjab.91.423","journal-title":"Proc Jpn Acad Ser B Phys Biol Sci"},{"issue":"9","key":"9773_CR66","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/nrmicro2384","volume":"8","author":"RA Strugnell","year":"2010","unstructured":"Strugnell RA, Wijburg OL (2010) The role of secretory antibodies in infection immunity. Nat Rev Microbiol 8(9):656\u2013667. https:\/\/doi.org\/10.1038\/nrmicro2384","journal-title":"Nat Rev Microbiol"},{"issue":"12","key":"9773_CR67","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1006\/cyto.1998.0385","volume":"10","author":"ME Goodrich","year":"1998","unstructured":"Goodrich ME, McGee DW (1998) Regulation of mucosal B cell immunoglobulin secretion by intestinal epithelial cell-derived cytokines. Cytokine 10(12):948\u2013955. https:\/\/doi.org\/10.1006\/cyto.1998.0385","journal-title":"Cytokine"},{"issue":"10","key":"9773_CR68","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1038\/nri1203","volume":"3","author":"EJ Kunkel","year":"2003","unstructured":"Kunkel EJ, Butcher EC (2003) Plasma-cell homing. Nat Rev Immunol 3(10):822\u2013829. https:\/\/doi.org\/10.1038\/nri1203","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"9773_CR69","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1021\/acs.bioconjchem.7b00738","volume":"29","author":"S Longet","year":"2018","unstructured":"Longet S, Lundahl MLE, Lavelle EC (2018) Targeted strategies for mucosal vaccination. Bioconjug Chem 29(3):613\u2013623. https:\/\/doi.org\/10.1021\/acs.bioconjchem.7b00738","journal-title":"Bioconjug Chem"},{"issue":"1","key":"9773_CR70","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.ijpharm.2012.04.047","volume":"440","author":"JF Correia-Pinto","year":"2013","unstructured":"Correia-Pinto JF, Csaba N, Alonso MJ (2013) Vaccine delivery carriers: insights and future perspectives. Int J Pharm 440(1):27\u201338. https:\/\/doi.org\/10.1016\/j.ijpharm.2012.04.047","journal-title":"Int J Pharm"},{"issue":"6","key":"9773_CR71","doi-asserted-by":"publisher","first-page":"761","DOI":"10.4161\/19490976.2014.972238","volume":"5","author":"A Dupont","year":"2014","unstructured":"Dupont A, Heinbockel L, Brandenburg K, Hornef MW (2014) Antimicrobial peptides and the enteric mucus layer act in concert to protect the intestinal mucosa. Gut Microbes 5(6):761\u2013765. https:\/\/doi.org\/10.4161\/19490976.2014.972238","journal-title":"Gut Microbes"},{"key":"9773_CR72","doi-asserted-by":"publisher","unstructured":"McEntee C, Lavelle EC, O\u2019Hagan DT (2015) Chapter 63 - Antigen delivery systems I: nonliving microparticles, liposomes, and immune-stimulating complexes (ISCOMs). In: Mestecky J, Strober W, Russell MW, Kelsall BL, Cheroutre H, Lambrecht BN (eds) Mucosal Immunology (Fourth Edition). Academic Press, Boston, pp 1211\u20131231. https:\/\/doi.org\/10.1016\/B978-0-12-415847-4.00063-X","DOI":"10.1016\/B978-0-12-415847-4.00063-X"},{"issue":"2","key":"9773_CR73","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1111\/jam.13446","volume":"123","author":"K Szatraj","year":"2017","unstructured":"Szatraj K, Szczepankowska AK, Chmielewska-Jeznach M (2017) Lactic acid bacteria - promising vaccine vectors: possibilities, limitations, doubts. J Appl Microbiol 123(2):325\u2013339. https:\/\/doi.org\/10.1111\/jam.13446","journal-title":"J Appl Microbiol"},{"issue":"7","key":"9773_CR74","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1038\/nmat2784","volume":"9","author":"T Nochi","year":"2010","unstructured":"Nochi T, Yuki Y, Takahashi H, Sawada S, Mejima M, Kohda T, Harada N, Kong IG, Sato A, Kataoka N, Tokuhara D, Kurokawa S, Takahashi Y, Tsukada H, Kozaki S, Akiyoshi K, Kiyono H (2010) Nanogel antigenic protein-delivery system for adjuvant-free intranasal vaccines. Nat Mater 9(7):572\u2013578. https:\/\/doi.org\/10.1038\/nmat2784","journal-title":"Nat Mater"},{"key":"9773_CR75","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.addr.2015.03.007","volume":"91","author":"CJ Davitt","year":"2015","unstructured":"Davitt CJ, Lavelle EC (2015) Delivery strategies to enhance oral vaccination against enteric infections. Adv Drug Deliv Rev 91:52\u201369. https:\/\/doi.org\/10.1016\/j.addr.2015.03.007","journal-title":"Adv Drug Deliv Rev"},{"key":"9773_CR76","doi-asserted-by":"publisher","first-page":"6012053","DOI":"10.1155\/2018\/6012053","volume":"2018","author":"D Calzada","year":"2018","unstructured":"Calzada D, Baos S, Cremades-Jimeno L, Cardaba B (2018) Immunological mechanisms in allergic diseases and allergen tolerance: the role of Treg cells. J Immunol Res 2018:6012053. https:\/\/doi.org\/10.1155\/2018\/6012053","journal-title":"J Immunol Res"},{"issue":"1","key":"9773_CR77","doi-asserted-by":"publisher","first-page":"148","DOI":"10.3390\/vaccines3010148","volume":"3","author":"HF Savelkoul","year":"2015","unstructured":"Savelkoul HF, Ferro VA, Strioga MM, Schijns VE (2015) Choice and design of adjuvants for parenteral and mucosal vaccines. Vaccines (Basel) 3(1):148\u2013171. https:\/\/doi.org\/10.3390\/vaccines3010148","journal-title":"Vaccines (Basel)"},{"issue":"5","key":"9773_CR78","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/nrmicro1840","volume":"6","author":"JM Wells","year":"2008","unstructured":"Wells JM, Mercenier A (2008) Mucosal delivery of therapeutic and prophylactic molecules using lactic acid bacteria. Nat Rev Microbiol 6(5):349\u2013362. https:\/\/doi.org\/10.1038\/nrmicro1840","journal-title":"Nat Rev Microbiol"},{"key":"9773_CR79","doi-asserted-by":"publisher","first-page":"1459394","DOI":"10.1155\/2016\/1459394","volume":"2016","author":"S Apostolico Jde","year":"2016","unstructured":"Apostolico Jde S, Lunardelli VA, Coirada FC, Boscardin SB, Rosa DS (2016) Adjuvants: classification, modus operandi, and licensing. J Immunol Res 2016:1459394. https:\/\/doi.org\/10.1155\/2016\/1459394","journal-title":"J Immunol Res"},{"issue":"9","key":"9773_CR80","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/S1473-3099(11)70099-8","volume":"11","author":"M Hedayat","year":"2011","unstructured":"Hedayat M, Netea MG, Rezaei N (2011) Targeting of Toll-like receptors: a decade of progress in combating infectious diseases. Lancet Infect Dis 11(9):702\u2013712. https:\/\/doi.org\/10.1016\/S1473-3099(11)70099-8","journal-title":"Lancet Infect Dis"},{"issue":"7","key":"9773_CR81","doi-asserted-by":"publisher","first-page":"4275","DOI":"10.4049\/jimmunol.176.7.4275","volume":"176","author":"S Chabot","year":"2006","unstructured":"Chabot S, Wagner JS, Farrant S, Neutra MR (2006) TLRs regulate the gatekeeping functions of the intestinal follicle-associated epithelium. J Immunol 176(7):4275\u20134283. https:\/\/doi.org\/10.4049\/jimmunol.176.7.4275","journal-title":"J Immunol"},{"issue":"3","key":"9773_CR82","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1007\/s13238-014-0125-1","volume":"6","author":"X Wang","year":"2015","unstructured":"Wang X, Meng D (2015) Innate endogenous adjuvants prime to desirable immune responses via mucosal routes. Protein Cell 6(3):170\u2013184. https:\/\/doi.org\/10.1007\/s13238-014-0125-1","journal-title":"Protein Cell"},{"issue":"4","key":"9773_CR83","first-page":"217","volume":"83","author":"HA Carleton","year":"2010","unstructured":"Carleton HA (2010) Pathogenic bacteria as vaccine vectors: teaching old bugs new tricks. Yale J Biol Med 83(4):217\u2013222","journal-title":"Yale J Biol Med"},{"key":"9773_CR84","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.copbio.2018.01.028","volume":"53","author":"ZJ Mays","year":"2018","unstructured":"Mays ZJ, Nair NU (2018) Synthetic biology in probiotic lactic acid bacteria: at the frontier of living therapeutics. Curr Opin Biotechnol 53:224\u2013231. https:\/\/doi.org\/10.1016\/j.copbio.2018.01.028","journal-title":"Curr Opin Biotechnol"},{"issue":"1","key":"9773_CR85","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1002\/bab.1822","volume":"67","author":"M Yadav","year":"2020","unstructured":"Yadav M, Shukla P (2020) Efficient engineered probiotics using synthetic biology approaches: a review. Biotechnol Appl Biochem 67(1):22\u201329. https:\/\/doi.org\/10.1002\/bab.1822","journal-title":"Biotechnol Appl Biochem"},{"issue":"2","key":"9773_CR86","doi-asserted-by":"publisher","first-page":"146","DOI":"10.3390\/vaccines8020146","volume":"8","author":"DA Diaz-Dinamarca","year":"2020","unstructured":"Diaz-Dinamarca DA, Hernandez C, Escobar DF, Soto DA, Munoz GA, Badilla JF, Manzo RA, Carrion F, Kalergis AM, Vasquez AE (2020) mucosal vaccination with Lactococcus lactis-secreting surface immunological protein induces humoral and cellular immune protection against group B Streptococcus in a murine model. Vaccines (Basel) 8(2):146. https:\/\/doi.org\/10.3390\/vaccines8020146","journal-title":"Vaccines (Basel)"},{"key":"9773_CR87","doi-asserted-by":"publisher","unstructured":"LeCureux JS, Dean GA (2018) Lactobacillus mucosal vaccine vectors: immune responses against bacterial and viral antigens. Msphere 3 (3). https:\/\/doi.org\/10.1128\/mSphere.00061-18","DOI":"10.1128\/mSphere.00061-18"},{"issue":"6499","key":"9773_CR88","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1126\/science.abc1669","volume":"369","author":"MM Lamers","year":"2020","unstructured":"Lamers MM, Beumer J, van der Vaart J, Knoops K, Puschhof J, Breugem TI, Ravelli RBG, Paul van Schayck J, Mykytyn AZ, Duimel HQ, van Donselaar E, Riesebosch S, Kuijpers HJH, Schipper D, van de Wetering WJ, de Graaf M, Koopmans M, Cuppen E, Peters PJ, Haagmans BL, Clevers H (2020) SARS-CoV-2 productively infects human gut enterocytes. Science 369(6499):50\u201354. https:\/\/doi.org\/10.1126\/science.abc1669","journal-title":"Science"},{"key":"9773_CR89","doi-asserted-by":"publisher","unstructured":"Konturek PC, Harsch IA, Neurath MF, Zopf Y (2020) COVID-19 - more than respiratory disease: a gastroenterologist\u2019s perspective. J Physiol Pharmacol 71 (2). https:\/\/doi.org\/10.26402\/jpp.2020.2.02","DOI":"10.26402\/jpp.2020.2.02"},{"key":"9773_CR90","doi-asserted-by":"publisher","unstructured":"Zuo T, Zhang F, Lui GCY, Yeoh YK, Li AYL, Zhan H, Wan Y, Chung ACK, Cheung CP, Chen N, Lai CKC, Chen Z, Tso EYK, Fung KSC, Chan V, Ling L, Joynt G, Hui DSC, Chan FKL, Chan PKS, Ng SC (2020) Alterations in gut microbiota of patients with COVID-19 during time of hospitalization. Gastroenterology 159 (3):944\u2013955 e948. https:\/\/doi.org\/10.1053\/j.gastro.2020.05.048","DOI":"10.1053\/j.gastro.2020.05.048"},{"issue":"1","key":"9773_CR91","doi-asserted-by":"publisher","first-page":"147","DOI":"10.3785\/j.issn.1008-9292.2020.02.02","volume":"49","author":"K Xu","year":"2020","unstructured":"Xu K, Cai H, Shen Y, Ni Q, Chen Y, Hu S, Li J, Wang H, Yu L, Huang H, Qiu Y, Wei G, Fang Q, Zhou J, Sheng J, Liang T, Li L (2020) Management of corona virus disease-19 (COVID-19): the Zhejiang experience. Zhejiang Da Xue Xue Bao Yi Xue Ban 49(1):147\u2013157. https:\/\/doi.org\/10.3785\/j.issn.1008-9292.2020.02.02","journal-title":"Zhejiang Da Xue Xue Bao Yi Xue Ban"},{"key":"9773_CR92","doi-asserted-by":"publisher","unstructured":"Morais AHA, Passos TS, Maciel BLL, da Silva-Maia JK (2020) Can probiotics and diet promote beneficial immune modulation and purine control in coronavirus infection? Nutrients 12 (6). https:\/\/doi.org\/10.3390\/nu12061737","DOI":"10.3390\/nu12061737"},{"key":"9773_CR93","doi-asserted-by":"publisher","unstructured":"Feng Z, Wang Y, Qi W (2020) The small intestine, an underestimated site of SARS-CoV-2 infection: from red queen effect to probiotics. Preprints.org. https:\/\/doi.org\/10.20944\/preprints202003.0161.v1","DOI":"10.20944\/preprints202003.0161.v1"},{"issue":"3","key":"9773_CR94","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/1751-2980.12851","volume":"21","author":"QY Gao","year":"2020","unstructured":"Gao QY, Chen YX, Fang JY (2020) 2019 Novel coronavirus infection and gastrointestinal tract. J Dig Dis 21(3):125\u2013126. https:\/\/doi.org\/10.1111\/1751-2980.12851","journal-title":"J Dig Dis"},{"key":"9773_CR95","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1146\/annurev-immunol-020711-075001","volume":"30","author":"JM Brenchley","year":"2012","unstructured":"Brenchley JM, Douek DC (2012) Microbial translocation across the GI tract. Annu Rev Immunol 30:149\u2013173. https:\/\/doi.org\/10.1146\/annurev-immunol-020711-075001","journal-title":"Annu Rev Immunol"},{"key":"9773_CR96","doi-asserted-by":"publisher","unstructured":"Ghosh SS, Wang J, Yannie PJ, Ghosh S (2020) Intestinal barrier dysfunction, LPS translocation, and disease development. J Endocr Soc 4 (2):bvz039. https:\/\/doi.org\/10.1210\/jendso\/bvz039","DOI":"10.1210\/jendso\/bvz039"},{"key":"9773_CR97","doi-asserted-by":"publisher","first-page":"301","DOI":"10.3389\/fmicb.2020.00301","volume":"11","author":"D Zhang","year":"2020","unstructured":"Zhang D, Li S, Wang N, Tan HY, Zhang Z, Feng Y (2020) The cross-talk between gut microbiota and lungs in common lung diseases. Front Microbiol 11:301. https:\/\/doi.org\/10.3389\/fmicb.2020.00301","journal-title":"Front Microbiol"},{"key":"9773_CR98","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.3389\/fimmu.2019.01551","volume":"10","author":"N Li","year":"2019","unstructured":"Li N, Ma WT, Pang M, Fan QL, Hua JL (2019) The commensal microbiota and viral infection: a comprehensive review. Front Immunol 10:1551. https:\/\/doi.org\/10.3389\/fimmu.2019.01551","journal-title":"Front Immunol"},{"key":"9773_CR99","doi-asserted-by":"publisher","first-page":"5035371","DOI":"10.1155\/2017\/5035371","volume":"2017","author":"R Bingula","year":"2017","unstructured":"Bingula R, Filaire M, Radosevic-Robin N, Bey M, Berthon JY, Bernalier-Donadille A, Vasson MP, Filaire E (2017) Desired turbulence? Gut-lung axis, immunity, and lung cancer. J Oncol 2017:5035371. https:\/\/doi.org\/10.1155\/2017\/5035371","journal-title":"J Oncol"},{"issue":"1","key":"9773_CR100","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1002\/eji.201646721","volume":"48","author":"JP McAleer","year":"2018","unstructured":"McAleer JP, Kolls JK (2018) Contributions of the intestinal microbiome in lung immunity. Eur J Immunol 48(1):39\u201349. https:\/\/doi.org\/10.1002\/eji.201646721","journal-title":"Eur J Immunol"},{"key":"9773_CR101","doi-asserted-by":"publisher","unstructured":"Bradley KC, Finsterbusch K, Schnepf D, Crotta S, Llorian M, Davidson S, Fuchs SY, Staeheli P, Wack A (2019) Microbiota-driven tonic interferon signals in lung stromal cells protect from Influenza virus infection. Cell Rep 28 (1):245-256 e244. https:\/\/doi.org\/10.1016\/j.celrep.2019.05.105","DOI":"10.1016\/j.celrep.2019.05.105"},{"key":"9773_CR102","doi-asserted-by":"publisher","first-page":"189","DOI":"10.3389\/fpubh.2020.00189","volume":"8","author":"P Xie","year":"2020","unstructured":"Xie P, Ma W, Tang H, Liu D (2020) Severe COVID-19: a review of recent progress with a look toward the future. Front Public Health 8:189. https:\/\/doi.org\/10.3389\/fpubh.2020.00189","journal-title":"Front Public Health"},{"issue":"1","key":"9773_CR103","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.clinre.2014.10.008","volume":"39","author":"YM Lei","year":"2015","unstructured":"Lei YM, Nair L, Alegre ML (2015) The interplay between the intestinal microbiota and the immune system. Clin Res Hepatol Gastroenterol 39(1):9\u201319. https:\/\/doi.org\/10.1016\/j.clinre.2014.10.008","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"4","key":"9773_CR104","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1038\/nrg3182","volume":"13","author":"I Cho","year":"2012","unstructured":"Cho I, Blaser MJ (2012) The human microbiome: at the interface of health and disease. Nat Rev Genet 13(4):260\u2013270. https:\/\/doi.org\/10.1038\/nrg3182","journal-title":"Nat Rev Genet"},{"issue":"8","key":"9773_CR105","doi-asserted-by":"publisher","first-page":"e6759","DOI":"10.1371\/journal.pone.0006759","volume":"4","author":"SA Vanhoutvin","year":"2009","unstructured":"Vanhoutvin SA, Troost FJ, Hamer HM, Lindsey PJ, Koek GH, Jonkers DM, Kodde A, Venema K, Brummer RJ (2009) Butyrate-induced transcriptional changes in human colonic mucosa. PLoS One 4(8):e6759. https:\/\/doi.org\/10.1371\/journal.pone.0006759","journal-title":"PLoS One"},{"issue":"1","key":"9773_CR106","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/imr.12185","volume":"260","author":"LM Kato","year":"2014","unstructured":"Kato LM, Kawamoto S, Maruya M, Fagarasan S (2014) The role of the adaptive immune system in regulation of gut microbiota. Immunol Rev 260(1):67\u201375. https:\/\/doi.org\/10.1111\/imr.12185","journal-title":"Immunol Rev"},{"issue":"1","key":"9773_CR107","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.cell.2014.03.011","volume":"157","author":"Y Belkaid","year":"2014","unstructured":"Belkaid Y, Hand TW (2014) Role of the microbiota in immunity and inflammation. Cell 157(1):121\u2013141. https:\/\/doi.org\/10.1016\/j.cell.2014.03.011","journal-title":"Cell"},{"issue":"1","key":"9773_CR108","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1146\/annurev-animal-022114-111038","volume":"3","author":"KS Chattha","year":"2015","unstructured":"Chattha KS, Roth JA, Saif LJ (2015) Strategies for design and application of enteric viral vaccines. Annu Rev Anim Biosci 3(1):375\u2013395. https:\/\/doi.org\/10.1146\/annurev-animal-022114-111038","journal-title":"Annu Rev Anim Biosci"},{"issue":"5","key":"9773_CR109","doi-asserted-by":"publisher","first-page":"639","DOI":"10.4161\/19490976.2014.969972","volume":"5","author":"S Kandasamy","year":"2014","unstructured":"Kandasamy S, Chattha KS, Vlasova AN, Rajashekara G, Saif LJ (2014) Lactobacilli and Bifidobacteria enhance mucosal B cell responses and differentially modulate systemic antibody responses to an oral human rotavirus vaccine in a neonatal gnotobiotic pig disease model. Gut Microbes 5(5):639\u2013651. https:\/\/doi.org\/10.4161\/19490976.2014.969972","journal-title":"Gut Microbes"},{"issue":"1","key":"9773_CR110","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1093\/infdis\/jiw518","volume":"215","author":"VC Harris","year":"2017","unstructured":"Harris VC, Armah G, Fuentes S, Korpela KE, Parashar U, Victor JC, Tate J, de Weerth C, Giaquinto C, Wiersinga WJ, Lewis KD, de Vos WM (2017) Significant correlation between the infant gut microbiome and Rotavirus vaccine response in rural Ghana. J Infect Dis 215(1):34\u201341. https:\/\/doi.org\/10.1093\/infdis\/jiw518","journal-title":"J Infect Dis"},{"key":"9773_CR111","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.jconrel.2014.05.060","volume":"190","author":"H Kraan","year":"2014","unstructured":"Kraan H, Vrieling H, Czerkinsky C, Jiskoot W, Kersten G, Amorij JP (2014) Buccal and sublingual vaccine delivery. J Control Release 190:580\u2013592. https:\/\/doi.org\/10.1016\/j.jconrel.2014.05.060","journal-title":"J Control Release"},{"issue":"6","key":"9773_CR112","doi-asserted-by":"publisher","first-page":"e1900344","DOI":"10.1002\/biot.201900344","volume":"15","author":"SW Cho","year":"2020","unstructured":"Cho SW, Yim J, Seo SW (2020) Engineering tools for the development of recombinant lactic acid bacteria. Biotechnol J 15(6):e1900344. https:\/\/doi.org\/10.1002\/biot.201900344","journal-title":"Biotechnol J"},{"issue":"396","key":"9773_CR113","doi-asserted-by":"publisher","first-page":"396","DOI":"10.3389\/fmicb.2013.00396","volume":"4","author":"L Ruiz","year":"2013","unstructured":"Ruiz L, Margolles A, Sanchez B (2013) Bile resistance mechanisms in Lactobacillus and Bifidobacterium. Front Microbiol 4(396):396. https:\/\/doi.org\/10.3389\/fmicb.2013.00396","journal-title":"Front Microbiol"},{"issue":"1","key":"9773_CR114","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.phrs.2012.09.010","volume":"69","author":"IC Lee","year":"2013","unstructured":"Lee IC, Tomita S, Kleerebezem M, Bron PA (2013) The quest for probiotic effector molecules unraveling strain specificity at the molecular level. Pharmacol Res 69(1):61\u201374. https:\/\/doi.org\/10.1016\/j.phrs.2012.09.010","journal-title":"Pharmacol Res"},{"issue":"3","key":"9773_CR115","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/nrmicro2297","volume":"8","author":"S Lebeer","year":"2010","unstructured":"Lebeer S, Vanderleyden J, De Keersmaecker SC (2010) Host interactions of probiotic bacterial surface molecules: comparison with commensals and pathogens. Nat Rev Microbiol 8(3):171\u2013184. https:\/\/doi.org\/10.1038\/nrmicro2297","journal-title":"Nat Rev Microbiol"},{"issue":"Suppl 1","key":"9773_CR116","doi-asserted-by":"publisher","first-page":"4607","DOI":"10.1073\/pnas.1000092107","volume":"108","author":"JM Wells","year":"2011","unstructured":"Wells JM, Rossi O, Meijerink M, van Baarlen P (2011) Epithelial crosstalk at the microbiota-mucosal interface. Proc Natl Acad Sci U S A 108(Suppl 1):4607\u20134614. https:\/\/doi.org\/10.1073\/pnas.1000092107","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"9773_CR117","doi-asserted-by":"publisher","first-page":"35","DOI":"10.5740\/jaoacint.sge_green-johnson","volume":"95","author":"JM Green-Johnson","year":"2012","unstructured":"Green-Johnson JM (2012) Immunological responses to gut bacteria. J AOAC Int 95(1):35\u201349. https:\/\/doi.org\/10.5740\/jaoacint.sge_green-johnson","journal-title":"J AOAC Int"},{"issue":"1","key":"9773_CR118","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/nrmicro2690","volume":"10","author":"PA Bron","year":"2011","unstructured":"Bron PA, van Baarlen P, Kleerebezem M (2011) Emerging molecular insights into the interaction between probiotics and the host intestinal mucosa. Nat Rev Microbiol 10(1):66\u201378. https:\/\/doi.org\/10.1038\/nrmicro2690","journal-title":"Nat Rev Microbiol"},{"issue":"4","key":"9773_CR119","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1111\/j.1365-2672.1994.tb03443.x","volume":"77","author":"GR Gibson","year":"1994","unstructured":"Gibson GR, Wang X (1994) Regulatory effects of Bifidobacteria on the growth of other colonic bacteria. J Appl Bacteriol 77(4):412\u2013420. https:\/\/doi.org\/10.1111\/j.1365-2672.1994.tb03443.x","journal-title":"J Appl Bacteriol"},{"issue":"4","key":"9773_CR120","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.cell.2006.02.015","volume":"124","author":"S Akira","year":"2006","unstructured":"Akira S, Uematsu S, Takeuchi O (2006) Pathogen recognition and innate immunity. Cell 124(4):783\u2013801. https:\/\/doi.org\/10.1016\/j.cell.2006.02.015","journal-title":"Cell"},{"issue":"11","key":"9773_CR121","doi-asserted-by":"publisher","first-page":"8869","DOI":"10.1074\/jbc.C200651200","volume":"278","author":"SE Girardin","year":"2003","unstructured":"Girardin SE, Boneca IG, Viala J, Chamaillard M, Labigne A, Thomas G, Philpott DJ, Sansonetti PJ (2003) Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J Biol Chem 278(11):8869\u20138872. https:\/\/doi.org\/10.1074\/jbc.C200651200","journal-title":"J Biol Chem"},{"key":"9773_CR122","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3389\/fimmu.2018.00027","volume":"9","author":"T Kawashima","year":"2018","unstructured":"Kawashima T, Ikari N, Watanabe Y, Kubota Y, Yoshio S, Kanto T, Motohashi S, Shimojo N, Tsuji NM (2018) Double-stranded RNA derived from lactic acid bacteria augments Th1 immunity via interferon-beta from human dendritic cells. Front Immunol 9:27. https:\/\/doi.org\/10.3389\/fimmu.2018.00027","journal-title":"Front Immunol"},{"issue":"4","key":"9773_CR123","doi-asserted-by":"publisher","first-page":"e32588","DOI":"10.1371\/journal.pone.0032588","volume":"7","author":"K Jounai","year":"2012","unstructured":"Jounai K, Ikado K, Sugimura T, Ano Y, Braun J, Fujiwara D (2012) Spherical lactic acid bacteria activate plasmacytoid dendritic cells immunomodulatory function via TLR9-dependent crosstalk with myeloid dendritic cells. PLoS One 7(4):e32588. https:\/\/doi.org\/10.1371\/journal.pone.0032588","journal-title":"PLoS One"},{"key":"9773_CR124","doi-asserted-by":"crossref","unstructured":"Fuller R (1997) Probiotics 2: applications and practical aspects, vol 2. Springer Science & Business Media","DOI":"10.1007\/978-94-011-5860-2"},{"issue":"8","key":"9773_CR125","doi-asserted-by":"publisher","first-page":"4713","DOI":"10.1016\/S0021-9258(19)67707-0","volume":"266","author":"R Dziarski","year":"1991","unstructured":"Dziarski R (1991) Demonstration of peptidoglycan-binding sites on lymphocytes and macrophages by photoaffinity cross-linking. J Biol Chem 266(8):4713\u20134718","journal-title":"J Biol Chem"},{"issue":"8","key":"9773_CR126","doi-asserted-by":"publisher","first-page":"704","DOI":"10.4315\/0362-028X-53.8.704","volume":"53","author":"CF Fernandes","year":"1990","unstructured":"Fernandes CF, Shahani KM (1990) Anticarcinogenic and immunological properties of dietary Lactobacilli. J Food Prot 53(8):704\u2013710. https:\/\/doi.org\/10.4315\/0362-028X-53.8.704","journal-title":"J Food Prot"},{"issue":"4","key":"9773_CR127","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1128\/mr.55.4.733-751.1991","volume":"55","author":"S Bhakdi","year":"1991","unstructured":"Bhakdi S, Tranum-Jensen J (1991) Alpha-toxin of Staphylococcus aureus. Microbiol Rev 55(4):733\u2013751","journal-title":"Microbiol Rev"},{"issue":"9","key":"9773_CR128","doi-asserted-by":"publisher","first-page":"3295","DOI":"10.1182\/blood-2003-03-0727","volume":"102","author":"B Dubois","year":"2003","unstructured":"Dubois B, Chapat L, Goubier A, Papiernik M, Nicolas JF, Kaiserlian D (2003) Innate CD4+ CD25+ regulatory T cells are required for oral tolerance and inhibition of CD8+ T cells mediating skin inflammation. Blood 102(9):3295\u20133301. https:\/\/doi.org\/10.1182\/blood-2003-03-0727","journal-title":"Blood"},{"issue":"3","key":"9773_CR129","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1111\/j.1398-9995.2008.01825.x","volume":"64","author":"P Rigaux","year":"2009","unstructured":"Rigaux P, Daniel C, Hisbergues M, Muraille E, Hols P, Pot B, Pestel J, Jacquet A (2009) Immunomodulatory properties of Lactobacillus plantarum and its use as a recombinant vaccine against mite allergy. Allergy 64(3):406\u2013414. https:\/\/doi.org\/10.1111\/j.1398-9995.2008.01825.x","journal-title":"Allergy"},{"issue":"2","key":"9773_CR130","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.imbio.2013.08.012","volume":"219","author":"J You","year":"2014","unstructured":"You J, Dong H, Mann ER, Knight SC, Yaqoob P (2014) Probiotic modulation of dendritic cell function is influenced by ageing. Immunobiology 219(2):138\u2013148. https:\/\/doi.org\/10.1016\/j.imbio.2013.08.012","journal-title":"Immunobiology"},{"issue":"1","key":"9773_CR131","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s12934-015-0313-6","volume":"14","author":"O Cano-Garrido","year":"2015","unstructured":"Cano-Garrido O, Seras-Franzoso J, Garcia-Fruitos E (2015) Lactic acid bacteria: reviewing the potential of a promising delivery live vector for biomedical purposes. Microb Cell Fact 14(1):137. https:\/\/doi.org\/10.1186\/s12934-015-0313-6","journal-title":"Microb Cell Fact"},{"issue":"2","key":"9773_CR132","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3390\/medsci7020033","volume":"7","author":"Alagon Fernandez Del Campo","year":"2019","unstructured":"Campo Alagon Fernandez Del, P, De Orta Pando A, Straface JI, Lopez Vega JR, Toledo Plata D, Niezen Lugo SF, Alvarez Hernandez D, Barrientos Fortes T, Gutierrez-Kobeh L, Solano-Galvez SG, Vazquez-Lopez R (2019) The use of probiotic therapy to modulate the gut microbiota and dendritic cell responses in inflammatory bowel diseases. Med Sci (Basel) 7(2):33. https:\/\/doi.org\/10.3390\/medsci7020033","journal-title":"Med Sci (Basel)"},{"issue":"32","key":"9773_CR133","doi-asserted-by":"publisher","first-page":"7186","DOI":"10.3748\/wjg.v22.i32.7186","volume":"22","author":"A Gallo","year":"2016","unstructured":"Gallo A, Passaro G, Gasbarrini A, Landolfi R, Montalto M (2016) Modulation of microbiota as treatment for intestinal inflammatory disorders: an uptodate. World J Gastroenterol 22(32):7186\u20137202. https:\/\/doi.org\/10.3748\/wjg.v22.i32.7186","journal-title":"World J Gastroenterol"},{"issue":"6","key":"9773_CR134","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1097\/MOG.0b013e3282f0cffc","volume":"23","author":"M Boirivant","year":"2007","unstructured":"Boirivant M, Strober W (2007) The mechanism of action of probiotics. Curr Opin Gastroenterol 23(6):679\u2013692. https:\/\/doi.org\/10.1097\/MOG.0b013e3282f0cffc","journal-title":"Curr Opin Gastroenterol"},{"issue":"12","key":"9773_CR135","doi-asserted-by":"publisher","first-page":"e0225842","DOI":"10.1371\/journal.pone.0225842","volume":"14","author":"Z Abdo","year":"2019","unstructured":"Abdo Z, LeCureux J, LaVoy A, Eklund B, Ryan EP, Dean GA (2019) Impact of oral probiotic Lactobacillus acidophilus vaccine strains on the immune response and gut microbiome of mice. PLoS One 14(12):e0225842. https:\/\/doi.org\/10.1371\/journal.pone.0225842","journal-title":"PLoS One"},{"issue":"2","key":"9773_CR136","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/s0168-1605(98)00044-0","volume":"41","author":"WH Holzapfel","year":"1998","unstructured":"Holzapfel WH, Haberer P, Snel J, Schillinger U, Huis in\u2019t Veld JH, (1998) Overview of gut flora and probiotics. Int J Food Microbiol 41(2):85\u2013101. https:\/\/doi.org\/10.1016\/s0168-1605(98)00044-0","journal-title":"Int J Food Microbiol"},{"issue":"9","key":"9773_CR137","doi-asserted-by":"publisher","first-page":"2929","DOI":"10.1128\/IAI.58.9.2929-2934.1990","volume":"58","author":"M Iwaki","year":"1990","unstructured":"Iwaki M, Okahashi N, Takahashi I, Kanamoto T, Sugita-Konishi Y, Aibara K, Koga T (1990) Oral immunization with recombinant Streptococcus lactis carrying the Streptococcus mutans surface protein antigen gene. Infect Immun 58(9):2929\u20132934. https:\/\/doi.org\/10.1128\/IAI.58.9.2929-2934.1990","journal-title":"Infect Immun"},{"issue":"2","key":"9773_CR138","doi-asserted-by":"publisher","first-page":"e8749","DOI":"10.1590\/1414-431X20198749","volume":"53","author":"B Gunasekaran","year":"2020","unstructured":"Gunasekaran B, Gothandam KM (2020) A review on edible vaccines and their prospects. Braz J Med Biol Res 53(2):e8749. https:\/\/doi.org\/10.1590\/1414-431X20198749","journal-title":"Braz J Med Biol Res"},{"key":"9773_CR139","doi-asserted-by":"publisher","unstructured":"del Rio B, Redruello B, Fernandez M, Martin MC, Ladero V, Alvarez MA (2019) Lactic acid bacteria as a live delivery system for the in situ production of nanobodies in the human gastrointestinal tract. Front Microbiol 9 (3179).\u00a0https:\/\/doi.org\/10.3389\/fmicb.2018.03179","DOI":"10.3389\/fmicb.2018.03179"},{"issue":"11","key":"9773_CR140","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.it.2014.07.003","volume":"35","author":"Y Valdez","year":"2014","unstructured":"Valdez Y, Brown EM, Finlay BB (2014) Influence of the microbiota on vaccine effectiveness. Trends Immunol 35(11):526\u2013537. https:\/\/doi.org\/10.1016\/j.it.2014.07.003","journal-title":"Trends Immunol"},{"key":"9773_CR141","doi-asserted-by":"publisher","unstructured":"Chorny A, Puga I, Cerutti A (2010) Chapter 2 - innate signaling networks in mucosal IgA class switching. In: Fagarasan S, Cerutti A (eds) Advances in immunology, vol 107. Academic Press, pp 31-69. https:\/\/doi.org\/10.1016\/B978-0-12-381300-8.00002-2","DOI":"10.1016\/B978-0-12-381300-8.00002-2"},{"issue":"11","key":"9773_CR142","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1016\/j.vaccine.2004.09.015","volume":"23","author":"PS Ho","year":"2005","unstructured":"Ho PS, Kwang J, Lee YK (2005) Intragastric administration of Lactobacillus casei expressing transmissible gastroentritis coronavirus spike glycoprotein induced specific antibody production. Vaccine 23(11):1335\u20131342. https:\/\/doi.org\/10.1016\/j.vaccine.2004.09.015","journal-title":"Vaccine"},{"key":"9773_CR143","doi-asserted-by":"publisher","unstructured":"Wells JM (2011) Immunomodulatory mechanisms of lactobacilli. Microb Cell Fact 10 Suppl 1 (Suppl 1):S17. https:\/\/doi.org\/10.1186\/1475-2859-10-S1-S17","DOI":"10.1186\/1475-2859-10-S1-S17"},{"issue":"4","key":"9773_CR144","doi-asserted-by":"publisher","first-page":"150","DOI":"10.3390\/vaccines7040150","volume":"7","author":"AC Vilander","year":"2019","unstructured":"Vilander AC, Dean GA (2019) Adjuvant strategies for lactic acid bacterial mucosal vaccines. Vaccines (Basel) 7(4):150. https:\/\/doi.org\/10.3390\/vaccines7040150","journal-title":"Vaccines (Basel)"},{"issue":"3","key":"9773_CR145","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/s0167-5699(99)01575-3","volume":"21","author":"RM Hershberg","year":"2000","unstructured":"Hershberg RM, Mayer LF (2000) Antigen processing and presentation by intestinal epithelial cells - polarity and complexity. Immunol Today 21(3):123\u2013128. https:\/\/doi.org\/10.1016\/s0167-5699(99)01575-3","journal-title":"Immunol Today"},{"key":"9773_CR146","doi-asserted-by":"publisher","unstructured":"de Moreno de LeBlanc A, Galdeano CM, Chaves S, Perdig\u00f3n G (2016) Oral administration of L. Casei CRL 431 increases immunity in bronchus and mammary glands. Eur J Inflamm 3 (1):23-28. https:\/\/doi.org\/10.1177\/1721727x0500300105","DOI":"10.1177\/1721727x0500300105"},{"issue":"1 Suppl","key":"9773_CR147","doi-asserted-by":"publisher","first-page":"106S","DOI":"10.1177\/0148607111430817","volume":"36","author":"HD Holscher","year":"2012","unstructured":"Holscher HD, Czerkies LA, Cekola P, Litov R, Benbow M, Santema S, Alexander DD, Perez V, Sun S, Saavedra JM, Tappenden KA (2012) Bifidobacterium lactis Bb12 enhances intestinal antibody response in formula-fed infants: a randomized, double-blind, controlled trial. JPEN J Parenter Enteral Nutr 36(1 Suppl):106S-117S. https:\/\/doi.org\/10.1177\/0148607111430817","journal-title":"JPEN J Parenter Enteral Nutr"},{"issue":"5","key":"9773_CR148","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1203\/01.PDR.0000141955.47550.A0","volume":"56","author":"C Mullie","year":"2004","unstructured":"Mullie C, Yazourh A, Thibault H, Odou MF, Singer E, Kalach N, Kremp O, Romond MB (2004) Increased poliovirus-specific intestinal antibody response coincides with promotion of Bifidobacterium longum-infantis and Bifidobacterium breve in infants: a randomized, double-blind, placebo-controlled trial. Pediatr Res 56(5):791\u2013795. https:\/\/doi.org\/10.1203\/01.PDR.0000141955.47550.A0","journal-title":"Pediatr Res"},{"key":"9773_CR149","doi-asserted-by":"publisher","unstructured":"Perdig\u00f3n G, Alvarez S (1992) Probiotics and the immune state. In: Fuller R (ed) Probiotics: the scientific basis. Springer Netherlands, Dordrecht, pp 145-180. https:\/\/doi.org\/10.1007\/978-94-011-2364-8_7","DOI":"10.1007\/978-94-011-2364-8_7"},{"issue":"1","key":"9773_CR150","doi-asserted-by":"publisher","first-page":"171","DOI":"10.4049\/jimmunol.168.1.171","volume":"168","author":"HR Christensen","year":"2002","unstructured":"Christensen HR, Frokiaer H, Pestka JJ (2002) Lactobacilli differentially modulate expression of cytokines and maturation surface markers in murine dendritic cells. J Immunol 168(1):171\u2013178. https:\/\/doi.org\/10.4049\/jimmunol.168.1.171","journal-title":"J Immunol"},{"issue":"5","key":"9773_CR151","doi-asserted-by":"publisher","first-page":"280","DOI":"10.4161\/gmic.2.5.18255","volume":"2","author":"E Macho Fernandez","year":"2011","unstructured":"Macho Fernandez E, Pot B, Grangette C (2011) Beneficial effect of probiotics in IBD: are peptidogycan and NOD2 the molecular key effectors? Gut Microbes 2(5):280\u2013286. https:\/\/doi.org\/10.4161\/gmic.2.5.18255","journal-title":"Gut Microbes"},{"issue":"4","key":"9773_CR152","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1111\/j.1365-2567.2007.02800.x","volume":"124","author":"LH Zeuthen","year":"2008","unstructured":"Zeuthen LH, Fink LN, Frokiaer H (2008) Toll-like receptor 2 and nucleotide-binding oligomerization domain-2 play divergent roles in the recognition of gut-derived lactobacilli and Bifidobacteria in dendritic cells. Immunology 124(4):489\u2013502. https:\/\/doi.org\/10.1111\/j.1365-2567.2007.02800.x","journal-title":"Immunology"},{"issue":"1","key":"9773_CR153","first-page":"17","volume":"2","author":"A Mercenier","year":"2000","unstructured":"Mercenier A, Muller-Alouf H, Grangette C (2000) Lactic acid bacteria as live vaccines. Curr Issues Mol Biol 2(1):17\u201325","journal-title":"Curr Issues Mol Biol"},{"issue":"2","key":"9773_CR154","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.bpg.2003.10.006","volume":"18","author":"E Isolauri","year":"2004","unstructured":"Isolauri E, Salminen S, Ouwehand AC (2004) Microbial-gut interactions in health and disease. Probiotics. Best Pract Res Clin Gastroenterol 18(2):299\u2013313. https:\/\/doi.org\/10.1016\/j.bpg.2003.10.006","journal-title":"Probiotics. Best Pract Res Clin Gastroenterol"},{"key":"9773_CR155","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.3389\/fmicb.2018.01821","volume":"9","author":"PA Bron","year":"2018","unstructured":"Bron PA, Kleerebezem M (2018) Lactic acid bacteria for delivery of endogenous or engineered therapeutic molecules. Front Microbiol 9:1821. https:\/\/doi.org\/10.3389\/fmicb.2018.01821","journal-title":"Front Microbiol"},{"key":"9773_CR156","doi-asserted-by":"publisher","DOI":"10.4172\/2155-9899.1000548","author":"B Israr","year":"2018","unstructured":"Israr B, Kim J, Anam S, Anjum F (2018) Lactic acid bacteria as vectors: a novel approach for mucosal vaccine delivery. J Clin Cell. https:\/\/doi.org\/10.4172\/2155-9899.1000548","journal-title":"J Clin Cell"},{"issue":"8929","key":"9773_CR157","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1016\/s0140-6736(94)91708-6","volume":"344","author":"JM Saavedra","year":"1994","unstructured":"Saavedra JM, Bauman NA, Oung I, Perman JA, Yolken RH (1994) Feeding of Bifidobacterium bifidum and Streptococcus thermophilus to infants in hospital for prevention of diarrhoea and shedding of rotavirus. Lancet 344(8929):1046\u20131049. https:\/\/doi.org\/10.1016\/s0140-6736(94)91708-6","journal-title":"Lancet"},{"issue":"4","key":"9773_CR158","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.bj.2020.05.021","volume":"43","author":"HI Shih","year":"2020","unstructured":"Shih HI, Wu CJ, Tu YF, Chi CY (2020) Fighting COVID-19: a quick review of diagnoses, therapies, and vaccines. Biomed J 43(4):341\u2013354. https:\/\/doi.org\/10.1016\/j.bj.2020.05.021","journal-title":"Biomed J"},{"issue":"25","key":"9773_CR159","doi-asserted-by":"publisher","first-page":"3066","DOI":"10.1016\/j.vaccine.2014.03.022","volume":"32","author":"S Takei","year":"2014","unstructured":"Takei S, Omoto C, Kitagawa K, Morishita N, Katayama T, Shigemura K, Fujisawa M, Kawabata M, Hotta H, Shirakawa T (2014) Oral administration of genetically modified Bifidobacterium displaying HCV-NS3 multi-epitope fusion protein could induce an HCV-NS3-specific systemic immune response in mice. Vaccine 32(25):3066\u20133074. https:\/\/doi.org\/10.1016\/j.vaccine.2014.03.022","journal-title":"Vaccine"},{"issue":"5","key":"9773_CR160","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1007\/s00705-012-1589-z","volume":"158","author":"Z Yu","year":"2013","unstructured":"Yu Z, Huang Z, Sao C, Huang Y, Zhang F, Ma G, Chen Z, Zeng Z, Qiwen D, Zeng W (2013) Oral immunization of mice using Bifidobacterium longum expressing VP1 protein from enterovirus 71. Arch Virol 158(5):1071\u20131077. https:\/\/doi.org\/10.1007\/s00705-012-1589-z","journal-title":"Arch Virol"},{"issue":"2","key":"9773_CR161","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1128\/aem.68.2.917-922.2002","volume":"68","author":"LG Bermudez-Humaran","year":"2002","unstructured":"Bermudez-Humaran LG, Langella P, Miyoshi A, Gruss A, Guerra RT, Montes de Oca-Luna R, Le Loir Y (2002) Production of human papillomavirus type 16 E7 protein in Lactococcus lactis. Appl Environ Microbiol 68(2):917\u2013922. https:\/\/doi.org\/10.1128\/aem.68.2.917-922.2002","journal-title":"Appl Environ Microbiol"},{"issue":"3","key":"9773_CR162","doi-asserted-by":"publisher","first-page":"609","DOI":"10.18388\/abp.2014_1884","volume":"61","author":"K Szatraj","year":"2014","unstructured":"Szatraj K, Szczepankowska AK, Saczynska V, Florys K, Gromadzka B, Lepek K, Plucienniczak G, Szewczyk B, Zagorski-Ostoja W, Bardowski J (2014) Expression of avian influenza haemagglutinin (H5) and chicken interleukin 2 (chIL-2) under control of the ptcB promoter in Lactococcus lactis. Acta Biochim Pol 61(3):609\u2013614","journal-title":"Acta Biochim Pol"},{"issue":"Pt 1","key":"9773_CR163","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1099\/jmm.0.076430-0","volume":"64","author":"Z Zhou","year":"2015","unstructured":"Zhou Z, Gong S, Li XM, Yang Y, Guan R, Zhou S, Yao S, Xie Y, Ou Z, Zhao J, Liu Z (2015) Expression of Helicobacter pylori urease B on the surface of Bacillus subtilis spores. J Med Microbiol 64(Pt 1):104\u2013110. https:\/\/doi.org\/10.1099\/jmm.0.076430-0","journal-title":"J Med Microbiol"},{"issue":"1","key":"9773_CR164","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/s12934-015-0360-z","volume":"14","author":"K Kuczkowska","year":"2015","unstructured":"Kuczkowska K, Mathiesen G, Eijsink VG, Oynebraten I (2015) Lactobacillus plantarum displaying CCL3 chemokine in fusion with HIV-1 Gag derived antigen causes increased recruitment of T cells. Microb Cell Fact 14(1):169. https:\/\/doi.org\/10.1186\/s12934-015-0360-z","journal-title":"Microb Cell Fact"},{"issue":"10","key":"9773_CR165","doi-asserted-by":"publisher","first-page":"5025","DOI":"10.4049\/jimmunol.1501243","volume":"195","author":"V Chamcha","year":"2015","unstructured":"Chamcha V, Jones A, Quigley BR, Scott JR, Amara RR (2015) Oral immunization with a recombinant Lactococcus lactis-expressing HIV-1 antigen on group A Streptococcus Pilus induces strong mucosal immunity in the gut. J Immunol 195(10):5025\u20135034. https:\/\/doi.org\/10.4049\/jimmunol.1501243","journal-title":"J Immunol"},{"issue":"14","key":"9773_CR166","doi-asserted-by":"publisher","first-page":"3031","DOI":"10.1016\/j.vaccine.2020.02.036","volume":"38","author":"M Liu","year":"2020","unstructured":"Liu M, Zhong Y, Chen J, Liu Y, Tang C, Wang X, Zhang Y, Wang P, Logan SM, Chen W, Wei B (2020) Oral immunization of mice with a multivalent therapeutic subunit vaccine protects against Helicobacter pylori infection. Vaccine 38(14):3031\u20133041. https:\/\/doi.org\/10.1016\/j.vaccine.2020.02.036","journal-title":"Vaccine"},{"issue":"1","key":"9773_CR167","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s12896-018-0461-y","volume":"18","author":"AD Mustafa","year":"2018","unstructured":"Mustafa AD, Kalyanasundram J, Sabidi S, Song AA, Abdullah M, Abdul Rahim R, Yusoff K (2018) Proof of concept in utilizing in-trans surface display system of Lactobacillus plantarum as mucosal tuberculosis vaccine via oral administration in mice. BMC Biotechnol 18(1):63. https:\/\/doi.org\/10.1186\/s12896-018-0461-y","journal-title":"BMC Biotechnol"},{"key":"9773_CR168","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/j.ijbiomac.2020.05.239","volume":"160","author":"M Wang","year":"2020","unstructured":"Wang M, Fu T, Hao J, Li L, Tian M, Jin N, Ren L, Li C (2020) A recombinant Lactobacillus plantarum strain expressing the spike protein of SARS-CoV-2. Int J Biol Macromol 160:736\u2013740. https:\/\/doi.org\/10.1016\/j.ijbiomac.2020.05.239","journal-title":"Int J Biol Macromol"},{"key":"9773_CR169","doi-asserted-by":"publisher","first-page":"4638","DOI":"10.1038\/srep04638","volume":"4","author":"Y Nakayama","year":"2014","unstructured":"Nakayama Y, Moriya T, Sakai F, Ikeda N, Shiozaki T, Hosoya T, Nakagawa H, Miyazaki T (2014) Oral administration of Lactobacillus gasseri SBT2055 is effective for preventing influenza in mice. Sci Rep 4:4638. https:\/\/doi.org\/10.1038\/srep04638","journal-title":"Sci Rep"},{"issue":"1","key":"9773_CR170","doi-asserted-by":"publisher","first-page":"4812","DOI":"10.1038\/s41598-019-39602-7","volume":"9","author":"K Eguchi","year":"2019","unstructured":"Eguchi K, Fujitani N, Nakagawa H, Miyazaki T (2019) Prevention of respiratory syncytial virus infection with probiotic lactic acid bacterium Lactobacillus gasseri SBT2055. Sci Rep 9(1):4812. https:\/\/doi.org\/10.1038\/s41598-019-39602-7","journal-title":"Sci Rep"},{"issue":"3","key":"9773_CR171","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1111\/lam.13334","volume":"71","author":"A Akour","year":"2020","unstructured":"Akour A (2020) Probiotics and COVID-19: is there any link? Lett Appl Microbiol 71(3):229\u2013234. https:\/\/doi.org\/10.1111\/lam.13334","journal-title":"Lett Appl Microbiol"},{"issue":"2","key":"9773_CR172","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.jaci.2013.08.020","volume":"133","author":"R Luoto","year":"2014","unstructured":"Luoto R, Ruuskanen O, Waris M, Kalliomaki M, Salminen S, Isolauri E (2014) Prebiotic and probiotic supplementation prevents rhinovirus infections in preterm infants: a randomized, placebo-controlled trial. J Allergy Clin Immunol 133(2):405\u2013413. https:\/\/doi.org\/10.1016\/j.jaci.2013.08.020","journal-title":"J Allergy Clin Immunol"},{"key":"9773_CR173","doi-asserted-by":"publisher","unstructured":"Starosila D, Rybalko S, Varbanetz L, Ivanskaya N, Sorokulova I (2017) Anti-influenza activity of a Bacillus subtilis probiotic strain. Antimicrob Agents Chemother 61 (7). https:\/\/doi.org\/10.1128\/AAC.00539-17","DOI":"10.1128\/AAC.00539-17"},{"issue":"4","key":"9773_CR174","doi-asserted-by":"publisher","first-page":"788","DOI":"10.3390\/nu11040788","volume":"11","author":"DE Kiousi","year":"2019","unstructured":"Kiousi DE, Karapetsas A, Karolidou K, Panayiotidis MI, Pappa A, Galanis A (2019) Probiotics in extraintestinal diseases: current trends and new directions. Nutrients 11(4):788. https:\/\/doi.org\/10.3390\/nu11040788","journal-title":"Nutrients"},{"issue":"389","key":"9773_CR175","doi-asserted-by":"publisher","first-page":"389","DOI":"10.3389\/fmed.2020.00389","volume":"7","author":"G d'Ettorre","year":"2020","unstructured":"d\u2019Ettorre G, Ceccarelli G, Marazzato M, Campagna G, Pinacchio C, Alessandri F, Ruberto F, Rossi G, Celani L, Scagnolari C, Mastropietro C, Trinchieri V, Recchia GE, Mauro V, Antonelli G, Pugliese F, Mastroianni CM (2020) Challenges in the management of SARS-CoV2 infection: the role of oral bacteriotherapy as complementary therapeutic strategy to avoid the progression of COVID-19. Front Med (Lausanne) 7(389):389. https:\/\/doi.org\/10.3389\/fmed.2020.00389","journal-title":"Front Med (Lausanne)"},{"key":"9773_CR176","doi-asserted-by":"publisher","first-page":"948","DOI":"10.3389\/fimmu.2017.00948","volume":"8","author":"P Clua","year":"2017","unstructured":"Clua P, Kanmani P, Zelaya H, Tada A, Kober A, Salva S, Alvarez S, Kitazawa H, Villena J (2017) Peptidoglycan from Immunobiotic Lactobacillus rhamnosus improves resistance of infant mice to respiratory syncytial viral infection and secondary Pneumococcal Pneumonia. Front Immunol 8:948. https:\/\/doi.org\/10.3389\/fimmu.2017.00948","journal-title":"Front Immunol"},{"key":"9773_CR177","doi-asserted-by":"publisher","unstructured":"de Vrese M, Winkler P, Rautenberg P, Harder T, Noah C, Laue C, Ott S, Hampe J, Schreiber S, Heller K, Schrezenmeir J (2005) Effect of Lactobacillus gasseri PA 16\/8, Bifidobacterium longum SP 07\/3, B. bifidum MF 20\/5 on common cold episodes: a double blind, randomized, controlled trial. Clin Nutr 24 (4):481\u2013491. https:\/\/doi.org\/10.1016\/j.clnu.2005.02.006","DOI":"10.1016\/j.clnu.2005.02.006"},{"issue":"3","key":"9773_CR178","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.nut.2007.01.004","volume":"23","author":"M Olivares","year":"2007","unstructured":"Olivares M, Diaz-Ropero MP, Sierra S, Lara-Villoslada F, Fonolla J, Navas M, Rodriguez JM, Xaus J (2007) Oral intake of Lactobacillus fermentum CECT5716 enhances the effects of influenza vaccination. Nutrition 23(3):254\u2013260. https:\/\/doi.org\/10.1016\/j.nut.2007.01.004","journal-title":"Nutrition"},{"key":"9773_CR179","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3389\/fcimb.2020.00009","volume":"10","author":"R Enaud","year":"2020","unstructured":"Enaud R, Prevel R, Ciarlo E, Beaufils F, Wieers G, Guery B, Delhaes L (2020) The gut-lung axis in health and respiratory diseases: a place for inter-organ and inter-kingdom crosstalks. Front Cell Infect Microbiol 10:9. https:\/\/doi.org\/10.3389\/fcimb.2020.00009","journal-title":"Front Cell Infect Microbiol"},{"issue":"12","key":"9773_CR180","doi-asserted-by":"publisher","first-page":"e12966","DOI":"10.1111\/cmi.12966","volume":"20","author":"A Dumas","year":"2018","unstructured":"Dumas A, Bernard L, Poquet Y, Lugo-Villarino G, Neyrolles O (2018) The role of the lung microbiota and the gut-lung axis in respiratory infectious diseases. Cell Microbiol 20(12):e12966. https:\/\/doi.org\/10.1111\/cmi.12966","journal-title":"Cell Microbiol"},{"key":"9773_CR181","doi-asserted-by":"publisher","first-page":"9726786","DOI":"10.1155\/2019\/9726786","volume":"2019","author":"Y Wang","year":"2019","unstructured":"Wang Y, Pan CQ, Xing H (2019) Advances in gut microbiota of viral hepatitis cirrhosis. Biomed Res Int 2019:9726786. https:\/\/doi.org\/10.1155\/2019\/9726786","journal-title":"Biomed Res Int"},{"issue":"1","key":"9773_CR182","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1111\/j.1574-695X.2006.00130.x","volume":"48","author":"V Falcone","year":"2006","unstructured":"Falcone V, Mihm D, Neumann-Haefelin D, Costa C, Nguyen T, Pozzi G, Ricci S (2006) Systemic and mucosal immunity to respiratory syncytial virus induced by recombinant Streptococcus gordonii surface-displaying a domain of viral glycoprotein G. FEMS Immunol Med Microbiol 48(1):116\u2013122. https:\/\/doi.org\/10.1111\/j.1574-695X.2006.00130.x","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"8","key":"9773_CR183","doi-asserted-by":"publisher","first-page":"4079","DOI":"10.1128\/JVI.80.8.4079-4087.2006","volume":"80","author":"JS Lee","year":"2006","unstructured":"Lee JS, Poo H, Han DP, Hong SP, Kim K, Cho MW, Kim E, Sung MH, Kim CJ (2006) Mucosal immunization with surface-displayed severe acute respiratory syndrome coronavirus spike protein on Lactobacillus casei induces neutralizing antibodies in mice. J Virol 80(8):4079\u20134087. https:\/\/doi.org\/10.1128\/JVI.80.8.4079-4087.2006","journal-title":"J Virol"},{"issue":"4","key":"9773_CR184","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1016\/j.micinf.2005.10.020","volume":"8","author":"ML Oliveira","year":"2006","unstructured":"Oliveira ML, Areas AP, Campos IB, Monedero V, Perez-Martinez G, Miyaji EN, Leite LC, Aires KA, Lee Ho P (2006) Induction of systemic and mucosal immune response and decrease in Streptococcus pneumoniae colonization by nasal inoculation of mice with recombinant lactic acid bacteria expressing pneumococcal surface antigen A. Microbes Infect 8(4):1016\u20131024. https:\/\/doi.org\/10.1016\/j.micinf.2005.10.020","journal-title":"Microbes Infect"},{"issue":"2","key":"9773_CR185","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1086\/509807","volume":"195","author":"SB Hanniffy","year":"2007","unstructured":"Hanniffy SB, Carter AT, Hitchin E, Wells JM (2007) Mucosal delivery of a pneumococcal vaccine using Lactococcus lactis affords protection against respiratory infection. J Infect Dis 195(2):185\u2013193. https:\/\/doi.org\/10.1086\/509807","journal-title":"J Infect Dis"},{"issue":"5","key":"9773_CR186","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.micinf.2008.01.007","volume":"10","author":"IB Campos","year":"2008","unstructured":"Campos IB, Darrieux M, Ferreira DM, Miyaji EN, Silva DA, Areas AP, Aires KA, Leite LC, Ho PL, Oliveira ML (2008) Nasal immunization of mice with Lactobacillus casei expressing the pneumococcal surface protein A: induction of antibodies, complement deposition and partial protection against Streptococcus pneumoniae challenge. Microbes Infect 10(5):481\u2013488. https:\/\/doi.org\/10.1016\/j.micinf.2008.01.007","journal-title":"Microbes Infect"},{"issue":"2","key":"9773_CR187","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.virol.2010.08.007","volume":"407","author":"H Lei","year":"2010","unstructured":"Lei H, Xu Y, Chen J, Wei X, Lam DM (2010) Immunoprotection against influenza H5N1 virus by oral administration of enteric-coated recombinant Lactococcus lactis mini-capsules. Virology 407(2):319\u2013324. https:\/\/doi.org\/10.1016\/j.virol.2010.08.007","journal-title":"Virology"},{"key":"9773_CR188","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.virol.2014.07.011","volume":"464\u2013465","author":"SH Shi","year":"2014","unstructured":"Shi SH, Yang WT, Yang GL, Cong YL, Huang HB, Wang Q, Cai RP, Ye LP, Hu JT, Zhou JY, Wang CF, Li Y (2014) Immunoprotection against influenza virus H9N2 by the oral administration of recombinant Lactobacillus plantarumNC8 expressing hemagglutinin in BALB\/c mice. Virology 464\u2013465:166\u2013176. https:\/\/doi.org\/10.1016\/j.virol.2014.07.011","journal-title":"Virology"},{"issue":"3","key":"9773_CR189","doi-asserted-by":"publisher","first-page":"245","DOI":"10.4149\/av_2019_301","volume":"63","author":"S Shakoor","year":"2019","unstructured":"Shakoor S, Rao AQ, Shahid N, Yaqoob A, Samiullah TR, Shakoor S, Latif A, Tabassum B, Khan MAU, Shahid AA, Husnain T (2019) Role of oral vaccines as an edible tool to prevent infectious diseases. Acta Virol 63(3):245\u2013252. https:\/\/doi.org\/10.4149\/av_2019_301","journal-title":"Acta Virol"},{"issue":"4","key":"9773_CR190","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/74356","volume":"18","author":"K Savoie","year":"2000","unstructured":"Savoie K (2000) Edible vaccine success. Nat Biotechnol 18(4):367. https:\/\/doi.org\/10.1038\/74356","journal-title":"Nat Biotechnol"},{"issue":"2","key":"9773_CR191","doi-asserted-by":"publisher","first-page":"93","DOI":"10.4103\/0255-0857.32713","volume":"25","author":"P Lal","year":"2007","unstructured":"Lal P, Ramachandran VG, Goyal R, Sharma R (2007) Edible vaccines: current status and future. Indian J Med Microbiol 25(2):93\u2013102. https:\/\/doi.org\/10.4103\/0255-0857.32713","journal-title":"Indian J Med Microbiol"}],"container-title":["Probiotics and Antimicrobial Proteins"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12602-021-09773-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12602-021-09773-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12602-021-09773-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,24]],"date-time":"2021-09-24T18:23:16Z","timestamp":1632507796000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12602-021-09773-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,26]]},"references-count":191,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["9773"],"URL":"https:\/\/doi.org\/10.1007\/s12602-021-09773-9","relation":{},"ISSN":["1867-1306","1867-1314"],"issn-type":[{"value":"1867-1306","type":"print"},{"value":"1867-1314","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,26]]},"assertion":[{"value":"9 March 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}